(Q38086061)

28 August 2017

0 references

Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants (English)

1 reference

28 August 2017

main subject

arterial hypertension

0 references

0 references

0 references

1 reference

Setor Kwadzo Kunutsor

series ordinal

1

0 references

author name string

Tanefa Antoinette Apekey

series ordinal

2

1 reference

28 August 2017

Marinka Steur

series ordinal

3

1 reference

28 August 2017

publication date

2 March 2013

1 reference

European Journal of Epidemiology

28 August 2017

published in

1 reference

28 August 2017

volume

28

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

205-221

1 reference

The "sunshine deficit" and cardiovascular disease

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Plasma 25-hydroxyvitamin D levels and risk of incident hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Vitamin D and subsequent systolic hypertension among women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

A prospective study of serum 25-hydroxyvitamin D levels, blood pressure, and incident hypertension in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Systematic Review: Vitamin D and Cardiometabolic Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Methods for summarizing the risk associations of quantitative variables in epidemiologic studies in a consistent form

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Vitamin D deficiency and risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Reproducibility of serum 25-hydroxyvitamin d and vitamin D-binding protein levels over time in a prospective cohort study of black and white adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Meta-analysis of individual participant data: rationale, conduct, and reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Effect of vitamin D on blood pressure: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Common genetic determinants of vitamin D insufficiency: a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Genome-wide association study of circulating vitamin D levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Evaluation of genetic markers as instruments for Mendelian randomization studies on vitamin D

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Hypertension in primary hyperparathyroidism--reduction of blood pressure by long-term treatment with vitamin D (alphacalcidol). A double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Ultraviolet B and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Long-term effect of calcium-vitamin D(3) fortified milk on blood pressure and serum lipid concentrations in healthy older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Vitamin D insufficiency and health outcomes over 5 y in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

1,25-dihydroxyvitamin D3 reduces systolic blood pressure in hypertensive adults: a pilot feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Serum 25-hydroxyvitamin D, Ethnicity, and Blood Pressure in the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Effect of Cholecalciferol Supplementation During Winter Months in Patients With Hypertension: A Randomized, Placebo-Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-013-9790-2

Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults

21 January 2018

1 reference

12 December 2020

Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study

1 reference

12 December 2020

What is the optimal dietary intake of vitamin D for reducing fracture risk?

1 reference

12 December 2020

Overview of general physiologic features and functions of vitamin D.

1 reference

12 December 2020

Blood pressure is lowered by vitamin D (alphacalcidol) during long-term treatment of patients with intermittent hypercalcaemia. A double-blind, placebo-controlled study

1 reference

12 December 2020

Oral calcitriol for reduction of proteinuria in patients with IgA nephropathy: a randomized controlled trial

1 reference

12 December 2020

Relationship of mineral metabolism and long-term calcium and cholecalciferol supplementation to blood pressure in normotensive men.

1 reference

12 December 2020

Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction

1 reference

12 December 2020

Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey

1 reference

12 December 2020

Reduction of blood pressure by treatment with alphacalcidol. A double-blind, placebo-controlled study in subjects with impaired glucose tolerance

1 reference

12 December 2020

Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women

1 reference

12 December 2020

Relation of Vitamin D Deficiency to Cardiovascular Risk Factors, Disease Status, and Incident Events in a General Healthcare Population

1 reference

12 December 2020

Vitamin D intake and risk of incident hypertension: results from three large prospective cohort studies

1 reference

12 December 2020

Genetic regulation of vitamin D levels

1 reference

12 December 2020

Vitamin D, shedding light on the development of disease in peripheral arteries

1 reference

12 December 2020

Vitamin D levels and early mortality among incident hemodialysis patients

1 reference

12 December 2020

Double-blind randomized, crossover trial of calcium supplementation in essential hypertension

1 reference

12 December 2020

Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women

1 reference

12 December 2020

No significant effect of calcium and vitamin D supplementation on blood pressure and calcium metabolism in elderly Chinese.

1 reference

12 December 2020

Cardiovascular risk factors during estrogen-norethindrone and cholecalciferol treatment

1 reference

12 December 2020

Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial

1 reference

12 December 2020

Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations

1 reference

12 December 2020

10.1007/S10654-013-9790-2

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1034011823

0 references

1 reference